Shortened Red Blood Cell Lifespan Is Related to the Dose of Erythropoiesis-Stimulating Agents Requirement in Patients on Hemodialysis

Therapeutic Apheresis and Dialysis

Volumn 16, Issue 6, 2012, Pages 522-528

  Sato, Yasuyuki ^a   Mizuguchi, Takashi ^b   Shigenaga, Sawako ^b   Yoshikawa, Etsuko ^b   Chujo, Keiko ^a   Minakuchi, Jun ^a   Kawashima, Syu ^a  

^a Kawashima Hospital   (Japan)

^b Kamojima Kawashima Clinic   (Japan)

Author keywords

Alveolar respired carbon monoxide; Erythropoiesis stimulating agents; Hemodialysis; Red blood cell lifespan; Renal anemia

Indexed keywords

ANTIANEMIC AGENT; CARBON MONOXIDE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE LIFESPAN; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; NUTRITION; PRIORITY JOURNAL; RETICULOCYTE COUNT;

AGED; ANEMIA; CARBON MONOXIDE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE AGING; FEMALE; HEMATINICS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PULMONARY ALVEOLI; RENAL DIALYSIS; RETICULOCYTES; TIME FACTORS;

EID: 84870561010     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2012.01089.x     Document Type: Article

References (43)

1. Artunc F, Risler T. Serum erythropoietin concentrations and responses to anaemia in patients with chronic kidney disease. Nephrol Dial Transplant 2007;22:2900-8.
2. Baer AN, Dessypris EN, Goldwasser E, Krantz SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987;66:559-64.
3. Guenter W, Lawrence T, Goodnough MD. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
4. Means RT, Dessypris EN, Krantz SB. Inhibition of human colony-forming units-erythroid by tumor necrosis factor requires accessory cells. J Clin Invest 1990;86:538-40.
5. Means RT, Dessypris EN, Krantz SB. Inhibition of human colony-forming units erythroid by interleukin-1 is mediated by gamma interferon. J Cell Physiol 1992;150:59-64.
6. Sitter T, Bergner A, Schiff H. Dialysate related cytokine production and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 2000;15:1207-11.
7. Gately MK, Renzetti LM, Magram J etal. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.
8. Berg CP, Engels IH, Rothbart A etal. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-206.
9. Mandal D, Baudin-Creuza V, Bhattacharyya A etal. Caspase3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger1 (band3). J Biol Chem 2003;278:52551-8.
10. Taniguchi S, Dai C-H, Price JO, Krantz SB. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-1 receptors in human erythroid colony-forming cells. Blood 1997;90:2244-52.
11. Kruse A, Uehlinger DE, Gotch F, Kotanko P, Levin NW. Red blood lifespan, erythropoiesis and hemoglobin control: hemodialysis-from basic research to clinical trial. Contrib Nephrol 2008;161:247-54.
12. Dallalio G, Means RT Jr. Effects of oxidative stress on human erythroid colony formation: modulation by γ-interferon. J Lab Clin Med 2003;141:395-400.
13. Moldawer LL, Marano MA, Wei Fong Y etal. Cachectin/tumor necrosis factor alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989;3:1637-43.
14. Alvarez-Hernandez X, Liceaga J, Mckay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989;61:319-22.
15. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99:3505-16.
16. Vos FE, Schollum JB, Coulter CV etal. Red blood cell survival in long-term dialysis patients. Am J Kidney Dis 2011;58:591-8.
17. Strocchi A, Schwartz S, Ellefson M, Engel RR, Medina A, Levitt MD. A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 1992;120:392-9.
18. 51 as methods of measuring red cell life span in man. Blood 1963;22:459-65.
19. 14C cyanate as a tag for red cell survival in normal and uremic man. J Lab Clin Med 1997;89:823-8.
20. Virtue MA, Furne JK, Ho SB, Levitt MD. Use of alveolar carbon monoxide to measure the effect of Ribavirin on red blood cell survival. Am J Hematol 2004;76:107-13.
21. Mitlyng BL, Singh JA, Furne JK, Ruddy J, Levitt MD. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol 2006;81:432-8.
22. Matsusaki T, Morimatsu H, Takahashi T etal. Increased exhaled carbon monoxide concentration during living donor liver transplantation. Int J Mol Med 2008;21:75-81.
23. Medina A, Ellis C, Levitt MD. Use of alveolar carbon monoxide measurements to assess red blood cell survival in hemodialysis patients. Am J Hematol 1994;46:91-4.
24. Osteryoung J. Electrochemical methods of analysis. Methods Enzymol 1988;158:243-67.
25. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-13.
26. Hotta T, Ogawa H, Saito A, Ito A. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure. Int J Hematol 1991;54:195-200.
27. Swanepoel C, Jacobs P, Byrne MJ, Rayner B, Cassidy MJD, Meyer J. The effect of recombinant human erythropoietin on haematopoiesis in patients undergoing haemodialysis. S Afr Med J 1996;86:952-5.
28. Takemoto Y, Okumiya T, Tsuchida K, Nakatani T, Yamamoto K. Erythrocyte creatine as an index of the erythrocyte life span and erythropoiesis. Nephron 2000;86:513-4.
29. Jiao Y, Okumiya T, Saibara T etal. An enzymatic assay for erythrocyte creatine as an index of the erythrocyte life time. Clin Biochem 1998;31:59-65.
30. Okumiya T, Kageoka T, Hashimoto E, Park K, Sasaki M. Clinical usefulness of measurement of creatine contents in human erythrocytes as an index of erythropoiesis. Jpn J Clin Pathol 1992;40:165-71 [In Japanese].
31. Fehr J, Knob M. Comparison of red cell creatine level and reticulocyte count in appraising the severity of hemolytic processes. Blood 1979;53:966-76.
32. Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells: relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994;269:2399-404.
33. Lang KS, Duranton C, Poehlmann H etal. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-56.
34. McGrath LT, Douglas AF, McClean E etal. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin Chim Acta 1995;31:179-88.
35. Weinstein T, Changnac A, Korzets A etal. Haemolysis in haemodialysis patients: evidence for impaired defense mechanisms against oxidative stress. Nephrol Dial Transplant 2000;15:883-7.
36. Urena P, Eckardt K, Safari E etal. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy. Nephron 1991;59:384-93.
37. Meytes D, Andrew ED, Dukes PP, Massry SG. Effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981;67:1263-9.
38. Rogers J, Lacroix L, Durmowitz G, Kasschau K, Andriotakis J, Bridges KR. The role of cytokines in the regulation of ferritin expression. Adv Exp Med Biol 1994;61:1330-6.
39. Klempner MS, Dinarello CA, Gallin JJ etal. Human leukocyte pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest 1978;61:1330-6.
40. Fukushima T, Horike H, Fujiki S, Kitada S, Sasaki T, Kashihara N. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients. Ther Apher Dial 2009;13:213-9.
41. Leshke M, Rumpf K, Eisenhauer T etal. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int Suppl 1983;16:143-6.
42. Kooistra MP, Struyvenberg A, Van Es A. The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 1991;57:127-8.
43. Hurot JM, Cuchrat M, Haugh M, Fouque D. Effects of L-carnitine supplementation in maintenance hemodialysis patients. J Am Soc Nephrol 2002;13:708-14. PubMed.